Hemo Organic Ltd.

View in App
11.30 -0.20 ▼-1.7%

19 April 2024, 04:01:00 PM
Volume: 16,880

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.hemoorganicltd.com
Market Cap 3.92 Cr.
Enterprise Value(EV) 3.89 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.25 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 40.73 Trailing Twelve Months Ending 2023-12
Book Value / Share -0.24 Trailing Twelve Months Ending 2023-12
Price to Book Value -46.48 Calculated using Price: 11.30
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.35 Cr. 3,465,900 Shares
FaceValue 10
About Hemo Organic Ltd.
Dinesh Allorga incorporated as public limited Company in August 1992. It is engaged in production and sale of ayurvedic medicines and chemicals.

Hemo Organic Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Hemo Organic Ltd. Performance

View details >>
1 Day
-1.74%
1 Week
-5.99%
1 Month
+19.58%
3 Month
+58.71%
6 Month
+81.96%
1 Year
+24.18%
2 Year
-77.62%
5 Year
-33.53%
10 Year
+18.57%

Hemo Organic Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -7.77 -99.33 -19.17 -44.9 -61.38 -17.52 -53.35 -180.16 0
Return on Capital Employed (%) -7.51 -96.61 -19.17 -39.88 -43.09 -11.35 -44.09 -89.29 -486.91
Return on Assets (%) -7.67 -101.27 -11.32 -15.99 -14.38 -4.75 -47.99 -65.16 -36.17

Hemo Organic Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 0 0 0 0 0 0 0 0
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 0 0 1 1 1 0 0 0 0 0
Minority Int.
Equity & Liab. 1 0 1 1 1 0 0 0 0 0
Non Curr. Assets 1 0 0 0
Curr. Assets 0 0 1 1 1 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 1 0 1 1 1 0 0 0 0 0

Hemo Organic Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 0 0 1 0 0 0 0 0
Other Income 0
Total Income 0 0 1 0 0 0 0 0
Total Expenditure 0 0 -1 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0 0 0
Interest
Depreciation 0 0
Taxation
Exceptional Items -1
PAT 0 -1 0 0 0 0 0 0 0 0
Adjusted EPS 0 -2 0 0 0 0 0 0 0 0

Hemo Organic Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -1 0 0 0 0 0 0
Cash Fr. Inv. 0 1 0 0 0
Cash Fr. Finan. 0 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Hemo Organic Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 16.85 16.85 16.85 16.85 16.85 16.85 16.85 16.85 16.85
Public 83.15 83.15 83.15 83.15 83.15 83.15 83.15 83.15 83.15
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Hemo Organic Ltd. Announcements

View details >>
Thu, 18 Apr 2024
Board Meeting Outcome for Appointment Of Mr. Anand Lavingia Practicing Company Secretary As Secretarial Auditor For Obtaining Secretarial Audit Report For Financial Year 2023-24.
In reference to captioned subject we hereby inform you that the Board of Directors of the Company in their Board Meeting held on today i.e. on April 18 2024 at the Registered Office of the Company which was commenced at 10:30 A.M. and concluded at 10:45 A.M. have appointed Mr. Anand Lavingia Practicing Company Secretary as Secretarial Auditor of the Company for obtaining the Secretarial Audit Report for the financial year 2023-24 (brief Profile of Mr. Anand Lavingia is attached herewith as Annexure).
Thu, 18 Apr 2024
Announcement under Regulation 30 (LODR)-Change in Management
In reference to the captioned subject we hereby inform you that the board of directors of the company in their meeting held on today ie. April 18 2024 at the registered office of the company which was commenced at 10:30 AM and concluded at 10:45 AM appointed Mr. Anand Lavingia Practicing Company Secretary as Secretarial Auditor of the company for obtaining secretarial audit report for the financial year 2023-24.
Wed, 17 Apr 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Hemo Organic Limited
2 CIN NO. L24231GJ1992PLC018224
3 Report filed for FY 2023-2024
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* 2023-24 2024-25 2025-26
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)2023-24 2024-25 2025-26
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-DINESHBHAI SHANABHAI PATEL
Designation :-CHAIRMAN AND MANAGING DIRECTOR
Name of the Chief Financial Officer :- DINESHBHAI SHANABHAI PATEL
Designation : -CHAIRMAN AND MANAGING DIRECTOR

Date: 17/04/2024

Hemo Organic Ltd. Technical Scans

View details >>
Fri, 19 Apr 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone

Hemo Organic Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 365,310.75 1,525.00 +0.5%
Cipla Ltd. 108,622.88 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. 99,134.26 5,942.65 -0.3%
Divi's Laboratories Ltd. 97,408.39 3,673.85 -1.2%
Mankind Pharma Ltd. 93,565.44 2,362.00 -1.5%
Zydus Lifesciences Ltd. 92,794.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. 88,715.85 6,152.25 +1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.02 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 29.29 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 18.96 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 70.43 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 54.18 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.20 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 112.40 6,152.25 +1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 4.19 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.69 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 7.47 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.53 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.92 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.14 6,152.25 +1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,152.25 +1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,152.25 +1.4%

Hemo Organic Ltd. FAQ's

What is Hemo Organic share price?
Can I buy Hemo Organic shares now?
What is the Market Cap of Hemo Organic?
What is the 52 Week High and Low of Hemo Organic?
What is the trend of Hemo Organic share price?